About Johnson & Johnson
Johnson & Johnson (JNJ) is a Healthcare company in the Pharmaceutical Preparations industry with a market capitalisation of $649.9B. The stock trades at 30.86x trailing earnings and yields 1.98%.
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Market cap
- $649.9B
- P/E ratio
- 30.86
- EPS (TTM)
- $11.03
- Revenue (TTM)
- $94.2B
- Free cash flow
- $19.7B
- Profit margin
- 28.5%
- Dividend yield
- 1.98%
- Shares outstanding
- 2.4B
Financial health: Strong8.3/10
6 strengths, 0 concerns. No red flags against these benchmarks.
- Debt to equity: 0.51 (Watch, benchmark < 0.5) — Debt of 0.51x equity is moderate against the 0.5x benchmark. It has deteriorated over the last 4 years.
- Net debt vs cash flow: 1.1y (Strong, benchmark < 4 years) — Net debt of $21.7B is 1.1x annual free cash flow — about a year of cash flow to repay.
- Current ratio: 1.03 (Watch, benchmark > 1.5) — Short-term assets cover 1.03x short-term liabilities, against Graham's 1.5x floor. It has been broadly flat over the last 4 years.
- Return on equity: 24.8% (Strong, benchmark > 15%) — Earns 24.8% on shareholder equity, comfortably past the > 15% mark.
- Gross margin: 67.9% (Strong, benchmark > 40%) — Keeps 67.9% of revenue after the direct cost of sales, comfortably past the > 40% mark.
- Net margin: 28.5% (Strong, benchmark > 10%) — Turns 28.5% of revenue into profit, comfortably past the > 10% mark.
- Free cash flow: $19.7B (Strong, benchmark positive) — Generated $19.7B of free cash flow after capital spending. It has improved over the last 4 years.
- Revenue growth: 6.0% (Watch, benchmark > 10%) — Revenue changed 6.0% year on year, short of the > 10% mark.
- Earnings growth: 90.6% (Strong, benchmark > 10%) — Earnings changed 90.6% year on year, comfortably past the > 10% mark.